Optimizing the Use of Sunitinib in Metastatic Renal Cell Carcinoma: An Update From Clinical Practice

By Schmidinger Manuela   Arnold Dirk   Szczylik Cezary   Wagstaff John   Ravaud Alain  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 856-864

Informa Healthcare

Access to resources Recommend Favorite

Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema

By Shuto Takashi   Matsunaga Shigeo   Suenaga Jun   Inomori Shigeo   Fujino Hideyo  

Journal of Neuro-Oncology, Vol. 98, Iss. 2, 2010-06 ,pp. : 169-175

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah   Larkin James   Pickering Lisa  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status

By Ohno Yoshio   Nakashima Jun   Ohori Makoto   Tanaka Ayako   Hashimoto Takeshi   Gondo Tatsuo   Hatano Tadashi   Tachibana Masaaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 139-145

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

By Kang Myoung  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3163-3172

Springer Publishing Company

Access to resources Recommend Favorite